Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Mar;14(3):292-6.
doi: 10.3779/j.issn.1009-3419.2011.03.17.

[The molecular markers related to personalized therapy of non-small cell lung cancer]

[Article in Chinese]
Affiliations
Review

[The molecular markers related to personalized therapy of non-small cell lung cancer]

[Article in Chinese]
Nannan Guo et al. Zhongguo Fei Ai Za Zhi. 2011 Mar.
No abstract available

PubMed Disclaimer

Similar articles

Cited by

References

    1. Molinari A, Calcabrini A, Meschini S, et al. Detection of P-glycoprotein. Int J Cancer. 1998;75(6):885–893. doi: 10.1002/(ISSN)1097-0215. - DOI - PubMed
    1. Shapiro AB, Fox K, Lee P, et al. Functional intracellular P-glycoprotein. Int J Cancer. 1998;76(6):857–864. doi: 10.1002/(ISSN)1097-0215. - DOI - PubMed
    1. Raez LE, Lilenbaum R. New developments in chemotherapy for advanced non-small cell lung cancer. http://www.ncbi.nlm.nih.gov/pubmed/16462185/ Curr Opin Oncol. 2006;18(2):156. - PubMed
    1. Eismann U, Oberschmidt O, Ehnert M, et al. Thymidylate synthase gene expression in solid tumors predicts for response to Pemetrexed in vitro. J Clin Oncol. 2006;24(Suppl):13058.
    1. Bepler G, Shama S, Cantor A, et al. RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer. J Clin Oncol. 2004;22(10):1878–1885. doi: 10.1200/JCO.2004.12.002. - DOI - PubMed

Publication types

MeSH terms

Substances